Paper25112
Beta-blockers and plasma triglycerides.
Shaw J and 2 others. Br Med J, 1978. Cited by 127 papers, by iCite.
Cite this record
ConductScience Library. Beta-blockers and plasma triglycerides. Papers, record 25112. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25112
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic beta-Antagonists | Major topic |
| Triglycerides | Major topic |
| Humans | |
| Hypertension |
Source PubMed
References2
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17448 | Beta-blockers and lipid metabolism. | Br Med J | 1977 | https://conductscience.org/library/papers/17448 | PubMed |
| 2 | 6244 | Metabolic effects of beta-adrenoreceptor blockers. | Drugs | 1976 | https://conductscience.org/library/papers/6244 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7903148 | Adverse reactions with beta-adrenoceptor blocking drugs. An update. | Drug Saf | 1993 | https://conductscience.org/library/papers/7903148 | PubMed |
| 7286043 | Serum lipoprotein changes during atenolol treatment of essential hypertension. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7286043 | PubMed |
| 7104159 | Effect of pindolol on serum lipids and lipid metabolizing enzymes. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7104159 | PubMed |
| 7093112 | The short term effects of propranolol, atenolol and labetalol on antipyrine kinetics in normal subjects. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093112 | PubMed |
| 7037030 | Oxprenolol, methyldopa and lipids in diabetes mellitus. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7037030 | PubMed |
| 6992822 | Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6992822 | PubMed |
| 6886585 | Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977. | J Epidemiol Community Health | 1983 | https://conductscience.org/library/papers/6886585 | PubMed |
| 6732988 | Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease. | Br Heart J | 1984 | https://conductscience.org/library/papers/6732988 | PubMed |
| 6143851 | [Antihypertensive therapy and lipid metabolism]. | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6143851 | PubMed |
| 6143567 | The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6143567 | PubMed |
| 6127218 | Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6127218 | PubMed |
| 6124416 | Diuretics of beta-blockers first for hypertension? | Drugs | 1982 | https://conductscience.org/library/papers/6124416 | PubMed |
| 6122737 | What should we do about mild hypertension? | J R Coll Physicians Lond | 1982 | https://conductscience.org/library/papers/6122737 | PubMed |
| 6122483 | Adrenergic mechanisms in control of plasma lipid concentrations. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6122483 | PubMed |
| 6109778 | Are selective beta-adrenoceptor blocking drugs an advantage? | J R Coll Physicians Lond | 1981 | https://conductscience.org/library/papers/6109778 | PubMed |
| 3709628 | Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol. | Eur J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3709628 | PubMed |
| 3154682 | Comparison of the metabolic effects of long-term treatment with pindolol or atenolol by hypertensive patients. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/3154682 | PubMed |
| 2939871 | Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/2939871 | PubMed |
| 2894885 | Beta blockers, lipids, and coronary atherosclerosis: fact or fiction? | Br Med J (Clin Res Ed) | 1988 | https://conductscience.org/library/papers/2894885 | PubMed |
| 2877846 | The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs. | Drugs | 1986 | https://conductscience.org/library/papers/2877846 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25112
GET https://conductscience.org/api/papers/v1/25112/cited_by?page=2